Flossbach Von Storch Ag Amgen Inc Transaction History

Flossbach Von Storch Ag

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$268.87 - $324.56 $202,459 - $244,393	753 New	753 $214,000
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $2.76 Million - $3.29 Million	-12,760 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$197.81 - $242.74 $530,130 - $650,543	-2,680 Reduced 17.36%	12,760 $3.01 Million
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $2 Million - $2.65 Million	10,950 Added 243.88%	15,440 $3.13 Million
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $8.44 Million - $10.8 Million	-44,600 Reduced 90.85%	4,490 $1.08 Million
Q3 2019 Nov 08, 2019	BUY	$174.11 - $208.62 $87,055 - $104,310	500 Added 1.03%	49,090 $9.5 Million
Q2 2019 Aug 06, 2019	BUY	$166.7 - $195.41 $56,677 - $66,439	340 Added 0.7%	48,590 $8.95 Million
Q1 2019 May 02, 2019	BUY	$180.87 - $203.88 $578,784 - $652,416	3,200 Added 7.1%	48,250 $9.17 Million
Q4 2018 Feb 05, 2019	SELL	$178.4 - $208.25 $135,227 - $157,853	-758 Reduced 1.65%	45,050 $8.77 Million
Q3 2018 Nov 05, 2018	SELL	$185.29 - $208.89 $3.65 Million - $4.12 Million	-19,700 Reduced 30.07%	45,808 $9.5 Million
Q2 2018 Aug 08, 2018	BUY	$166.05 - $186.51 $896,670 - $1.01 Million	5,400 Added 8.98%	65,508 $12.1 Million
Q1 2018 May 04, 2018	SELL	$169.43 - $198.0 $12.1 Million - $14.1 Million	-71,292 Reduced 54.26%	60,108 $10.2 Million
Q4 2017 Feb 07, 2018	SELL	$168.79 - $188.59 $35.9 Million - $40.1 Million	-212,870 Reduced 61.83%	131,400 $22.9 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $57.6 Million - $65.8 Million	344,270	344,270 $64.2 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Flossbach Von Storch Ag, based on Form 13F filings with the SEC.

Stay updated on Flossbach Von Storch Ag with notifications on news.